Compare OneSpan Inc (OSPN) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
OneSpan Inc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? OneSpan Inc trades at $18.22 (market cap $662.97M), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.68 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 88.6× OneSpan Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold OneSpan Inc for 18 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| OSPN | TAK | |
|---|---|---|
Market Cap | $662.97M | $58.74B |
Volume | 616,882 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $18.42 | $19.05 |
52-Week Low | $10.15 | $13.23 |
Typical Hold Time | 18 Days | 1 Days |
Enterprise Value | $632.05M | $86.65B |
Dividend Yield | 2.89% | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSPN trades at $18.22, up 2.94% today, with a bullish technical signal from moving averages and recent earnings beats. The company shows strong profitability with a 27.76% net income margin and a reasonable P/E of 10.16. Analyst consensus is strongly positive with 10 buy ratings. Recent news highlights investor attention and a new product launch, DigipassONE, supporting growth prospects.
The outlook for OSPN is favorable given consistent earnings outperformance and solid fundamentals, though negative net cash flow and competitive pressures pose risks. Upside potential hinges on execution of its subscription revenue growth strategy and market adoption of new authentication solutions.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
